"The United States Food and Drug Administration (USFDA) conducted inspection at the company#39;s Ghaziabad formulation facility between August 19, 2019 to August 23, 2019. The inspection was a routine Good manufacturing practice (GMP) surveillance," Unichem said in a regulatory filing.USFDA issues one observation for Unichem#39;s Ghaziabad formulations facility
"The United States Food and Drug Administration (USFDA) conducted inspection at the company#39;s Ghaziabad formulation facility between August 19, 2019 to August 23, 2019. The inspection was a routine Good manufacturing practice (GMP) surveillance," Unichem said in a regulatory filing.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The bank plans to raise up to Rs 500 crore by issue of equity shares to qualified institutional buyers through qualified institutional plac...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment